Indaptus Therapeutics's top three insider shareholders as of August 04, 2026 are Michael James Newman (Cso And Director, 1.37Mn shares), Glen R. Anderson (TenPercentOwner, 1.19Mn shares), Michael James Newman (Cso And Director, 101.07K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Walt Addison Linscott | Chief Operating Officer | 54,426 | 0 | 29 Dec, 2025 |
| Nir Sassi | Chief Financial Officer | 26,758 | 0 | 29 Dec, 2025 |
| Michael James Newman | Cso And Director | 0 | 1,368,356 | 02 Feb, 2022 |
| Glen R. Anderson | - | 0 | 1,190,400 | 16 Aug, 2023 |
| Avraham Ben-Tzvi | - | 25,100 | 0 | 22 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 23 Mar, 2026 | David E. Lazar | Series AA Convertible Non-Redeemable Preferred Stock | D | 196,800 | - | 103,200 | D | S |
| 23 Mar, 2026 | David E. Lazar | Series AAA Convertible Non-Redeemable Preferred Stock | D | 700,000 | - | 0 | D | S |
| 20 Jan, 2026 | Avraham Ben-Tzvi | Common Stock | A | 25,000 | $0.00 | 25,100 | D | A |
| 23 Dec, 2025 | Avraham Ben-Tzvi | Option to Buy Common Stock | A | 25,000 | $0.00 | 25,000 | D | A |
| 22 Dec, 2025 | Nir Sassi | Common Stock | A | 26,758 | $2.03 | 26,758 | D | A |
| 22 Dec, 2025 | Walt Addison Linscott | Common Stock | A | 54,421 | $2.03 | 54,426 | D | A |
| 22 Dec, 2025 | Michael James Newman | Common Stock | A | 52,204 | $2.03 | 101,074 | D | A |
| 22 Dec, 2025 | Walt Addison Linscott | Common Stock | A | 54,421 | $2.03 | 54,426 | D | A |
| 22 Dec, 2025 | Nir Sassi | Common Stock | A | 26,758 | $2.03 | 26,758 | D | A |
| 22 Dec, 2025 | Nir Sassi | Common Stock | A | 26,758 | $2.03 | 26,758 | D | A |
| 22 Dec, 2025 | Michael James Newman | Common Stock | A | 52,204 | $2.03 | 101,074 | D | A |
| 22 Dec, 2025 | Michael James Newman | Common Stock | A | 52,204 | $2.03 | 101,074 | D | A |
| 22 Dec, 2025 | Walt Addison Linscott | Common Stock | A | 54,421 | $2.03 | 54,426 | D | A |
| 10 Jun, 2025 | Roger Pomerantz | Stock Option (right to buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 10 Jun, 2025 | William B Hayes | Stock Option (right to buy) | A | 12,500 | $0.00 | 12,500 | D | A |
| 10 Jun, 2025 | Mark John Gilbert | Stock Option (right to buy) | A | 12,500 | $0.00 | 12,500 | D | A |
| 10 Jun, 2025 | Hila Karah | Stock Option (right to buy) | A | 12,500 | $0.00 | 12,500 | D | A |
| 10 Jun, 2025 | Robert Martell | Stock Option (right to buy) | A | 12,500 | $0.00 | 12,500 | D | A |
| 10 Jun, 2025 | Robert Martell | Stock Option (right to buy) | A | 12,500 | $0.00 | 12,500 | D | A |
| 10 Jun, 2025 | Robert Martell | Stock Option (right to buy) | A | 12,500 | $0.00 | 12,500 | D | A |